[
    {
        "type": "http://www.w3.org/2002/07/owl#NamedIndividual",
        "left and not right": [
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/AluminumHydroxideAsActiveIngredientRole",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/AluminumPhosphateAsActiveIngredientRole"
        ],
        "right and not left": [
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/AluminumPhosphateAsActiveIngredient",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/AluminumHydroxideAsActiveIngredient"
        ],
        "both right and left": [
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/EngerixBAsInvestigationalMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/PfizerGmbHAsMarketingAuthorizationHolder",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/GlaxoSmithKlineBiologicalsSA",
            "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002112-16/GB",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/HepatitisBSurfaceAntigenAsActiveIngredient",
            "https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/heplisav",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/HeplisavAsInvestigationalMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/NorvascMarketingAuthorizationInGermany",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/ClinicalTrialAuthorization-2010-022372-31",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/ClinicalTrialAuthorization-2004-002410-11",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/FendrixAsAuthorizedMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/EudraClinicalTrialsNumber-2004-002410-11",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/NovartisPharmaServicesAGAuthorizedParty",
            "https://gsrs.ncats.nih.gov/api/v1/substances/bba69d15-f55c-4f0d-8e24-e61b60f2a115",
            "https://gsrs.ncats.nih.gov/api/v1/substances/e67c9314-1e17-4876-a745-47f27c2169e6",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/DynavaxTechnologiesCorporation",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/FendrixAsInvestigationalMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/FendrixPharmaceuticalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/NorvascAsAuthorizedMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/SheffieldTeachingHospitalsNHSFoundationTrustAuthorizedParty",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/EngerixBAsAuthorizedMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/EudraClinicalTrialsNumber-2010-022372-31",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/NovartisPharmaServicesAG",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/AliskirenMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/SheffieldTeachingHospitalsNHSFoundation",
            "https://gsrs.ncats.nih.gov/api/v1/substances/beaecfe8-eccb-44ab-b842-ae2cc60ff3e4",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/DynavaxTechnologiesCorporationAsAuthorizedParty",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/MarketingAuthorizationNumber-CPMP-1493-01",
            "https://gsrs.ncats.nih.gov/api/v1/substances/c9925b82-5d36-4e00-b54d-d3b7189625de",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/DynavaxTechnologiesCorporationAsMarketingAuthorizationHolder",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/Aliskiren",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/ClinicalTrialAuthorization-2014-002112-16",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/NorvascAsInvestigationalMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/AliskirenAsInvestigationalMedicinalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/FendrixMarketingAuthorizationInEuropeanUnion",
            "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002410-11/DE",
            "https://www.ema.europa.eu/en/medicines/human/EPAR/fendrix",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/EngerixBMarketingAuthorizationInEuropeanUnion",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/HeplisavPharmaceuticalProduct",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/PfizerGmbH",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/EudraClinicalTrialsNumber-2014-002112-16",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/GlaxoSmithKlineBiologicalsAsMarketingAuthorizationHolder",
            "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022372-31/DE",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/MarketingAuthorizationNumber-EMEA-H-C-000550",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/MonophosphorylLipidA-1-3-O-desacyl-4'AsActiveIngredient",
            "https://www.ema.europa.eu/en/medicines/human/referrals/engerix-b",
            "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/EuropeanUnionClinicalTrialsRegister/EngerixBPharmaceuticalProduct"
        ]
    }
]